Tirzepatide 30mg

Tirzepatide 30mg Overview

Tirzepatide is a synthetic peptide investigated for its activity at both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors.

This dual receptor activity distinguishes Tirzepatide from compounds investigated primarily as selective GLP-1 receptor agonists and has resulted in extensive scientific interest in incretin-receptor signalling.

Tirzepatide is a modified peptide containing 39 amino-acid residues and incorporates structural modifications relevant to its receptor activity and pharmacological characteristics.

Published literature includes substantial clinical as well as preclinical research. However, the product supplied by Interlink Peptides is sold exclusively as a laboratory research material and is not a medicinal product.

Interlink Peptides supplies Tirzepatide 30mg strictly for laboratory and scientific research applications.

Technical Specification

Compound: Tirzepatide
Quantity: 1 × 30mg vial
Form: Lyophilised powder
Peptide length: 39 amino-acid residues
CAS Number: 2023788-19-2
Molecular weight: Approximately 4,814 Da
Storage: −20 °C in lyophilised form
After reconstitution: Store refrigerated at 2–8 °C
Certificate of Analysis: Available where applicable

Exact analytical specifications should be confirmed using the Certificate of Analysis applicable to the relevant batch.

Research Background

Tirzepatide has been investigated extensively within incretin, metabolic and endocrine research.

Its defining research characteristic is activity involving two incretin receptors: GIP and GLP-1. This has enabled researchers to investigate combined receptor signalling and compare it with compounds targeting individual incretin pathways.

Published research includes studies examining receptor pharmacology, glucose metabolism, energy balance and wider metabolic signalling.

Tirzepatide is also the active pharmaceutical ingredient in licensed medicines. The existence of licensed pharmaceutical products does not mean research-grade Tirzepatide supplied by Interlink Peptides is suitable for therapeutic or human use.

Interlink Peptides makes no claims regarding weight loss, diabetes treatment, appetite reduction or other effects in humans and supplies this product exclusively for laboratory research.

Handling & Storage

Store Tirzepatide in its lyophilised form at approximately −20 °C, protected from light and moisture.

Once reconstituted with water, store refrigerated at approximately 2–8 °C.

Allow the sealed vial to reach an appropriate laboratory working temperature before opening to minimise condensation.

Avoid unnecessary repeated freeze-thaw cycles. Preparation, solvent selection and experimental handling should be determined according to the receiving laboratory’s own validated procedures.

Quality & Testing

Certificate of Analysis documentation is available where applicable.

Identity, purity and other analytical specifications should be confirmed against documentation associated with the relevant batch.

Explore our full range of research peptides for laboratory and scientific research applications.

Researchers investigating related incretin-receptor pathways can also view our Retatrutide research products.

Frequently Asked Questions

What is Tirzepatide?

Tirzepatide is a synthetic peptide investigated as a dual GIP and GLP-1 receptor agonist.

How many amino acids are in Tirzepatide?

Tirzepatide contains 39 amino-acid residues and incorporates additional structural modifications.

What receptors are associated with Tirzepatide research?

Tirzepatide has been investigated for activity involving both the GIP and GLP-1 receptors.

Is research Tirzepatide the same as a licensed medicine?

Tirzepatide is used as an active pharmaceutical ingredient in licensed medicines, but the product supplied by Interlink Peptides is a laboratory research material and is not supplied or represented as a medicinal product.

Is a Certificate of Analysis available?

Certificate of Analysis documentation is available where applicable. Exact analytical specifications should be checked against documentation for the relevant batch.

How should Tirzepatide be stored?

Store the lyophilised product at −20 °C, protected from light and moisture. Once reconstituted with water, store refrigerated at 2–8 °C.

Research Use Only

Interlink Peptides supplies Tirzepatide 30mg strictly for in-vitro laboratory and scientific research purposes.

This product is not intended for human or animal consumption, medical treatment, therapeutic use or clinical application.

We do not provide dosing or administration guidance. Purchasers are responsible for ensuring that their intended use complies with applicable laws and institutional requirements.